Loading company…
Stockholm-based Wilson Therapeutics AB is a biopharmaceutical company developing novel therapies for patients with rare diseases.
Founded in 2012 and based in Stockholm, Sweden, Wilson Therapeutics AB operates as a biopharmaceutical company. It develops novel therapies for patients with rare diseases. The company is listed at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in